Skip to main content

Settlement News Before Abilify Bellwether Trials Begin

Settlement News Before Abilify Bellwether Trials Begin

Settlement News Before Abilify Bellwether Trials Begin

Introduction

Come June, the first set of Abilify bellwether trials will begin. Judge M. Casey Rodgers presiding over the centralized Abilify litigation is pushing for the parties involved in the first three cases to settle the dispute before the trials begin. The judge has appointed Settlement Master Cathy Yanni to take this settlement matter further and ordered the parties’ legal representatives to meet as per the order released on April 25.

The first trial is scheduled to begin on June 18, followed by the second trial on August 6, and the third trial on August 27 to be convened at the federal court in Pensacola.

The Abilify lawsuits were centralized in October 2016 as a part of MDL No. 2734 (In Re: Abilify Compulsive Behavior Products Liability Litigation) in the U.S. District Court for the Northern District of Florida, where more than 800 product liability lawsuits are pending against the defendant drugmakers Bristol-Myers Squibb and Otsuka Pharmaceuticals.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!